People experiencing homelessness face disproportionately poor health outcomes due to medical mistrust rooted in systemic discrimination, past negative healthcare encounters, and fragmented access to services, leading to delayed care, avoidance of preventive services, and higher mortality from treatable conditions—a crisis exacerbated by gaps in trauma-informed care and provider bias across U.S. Safety-net systems.
The Hidden Toll of Distrust: How Systemic Failures Deepen Health Inequity
Medical mistrust among unhoused populations is not merely attitudinal—it is a rational response to repeated experiences of stigma, dehumanization, and clinical neglect. A 2025 longitudinal study published in JAMA Internal Medicine found that 68% of individuals experiencing chronic homelessness in major U.S. Urban centers reported avoiding emergency care due to anticipated discrimination, with 42% citing prior instances where providers dismissed symptoms as “drug-seeking” or “non-compliant.” This avoidance correlates directly with later-stage diagnoses of hypertension, diabetes, and tuberculosis—conditions that are highly manageable when caught early but become life-threatening without consistent care. The study, which followed 1,200 participants across Los Angeles, New York, and Chicago over 18 months, revealed that each episode of perceived discrimination increased the likelihood of subsequent care avoidance by 37%.
In Plain English: The Clinical Takeaway
- When people without stable housing avoid doctors due to past disrespect, treatable illnesses like high blood pressure or lung infections become dangerous emergencies.
- Trust isn’t built by pamphlets—it’s earned when clinicians listen without judgment, treat pain seriously, and follow up consistently.
- Health systems must train staff in trauma-informed care and partner with street medicine teams to meet people where they are—literally and figuratively.
Beyond Bias: The Biological and Behavioral Consequences of Avoidance
The physiological toll of delayed care is measurable. According to CDC mortality data from 2024, unhoused individuals in the U.S. Die an average of 17–20 years earlier than housed peers, with cardiovascular disease and infectious illnesses accounting for over 50% of excess deaths. A key driver is uncontrolled hypertension: a 2023 NIH-funded study in Hypertension found that only 29% of unhoused hypertensive patients achieved blood pressure control (<130/80 mmHg) compared to 54% of low-income housed individuals, largely due to inconsistent medication adherence driven by mistrust and instability. Latent tuberculosis infection (LTBI) progresses to active disease at rates 3–5 times higher in this population, per WHO surveillance data, not because of inherent susceptibility but due to delayed screening and incomplete treatment courses—often interrupted by shelter sweeps or incarceration.
These outcomes are not inevitable. In Boston, the BHCHP (Boston Health Care for the Homeless Program) reduced LTBI progression by 62% over five years by deploying nurse practitioners directly into encampments and using directly observed therapy (DOT) with peer navigators—individuals with lived experience of homelessness who build trust through shared identity. Similarly, San Francisco’s Street Team Medicine initiative increased HIV viral suppression rates from 41% to 68% in two years by offering low-threshold antiretroviral therapy (ART) initiation without requiring sobriety or housing stability as prerequisites.
Funding, Frameworks, and the Fight for Equity
The research underpinning these interventions has been supported by a mix of federal and private sources. The NIH’s National Institute on Minority Health and Health Disparities (NIMHD) awarded a $4.2 million R01 grant (2021–2026) to researchers at the University of California, San Francisco to study the impact of trauma-informed primary care models on hypertension control in unhoused populations—work that informed the San Francisco model. Meanwhile, the CDC’s Division of Tuberculosis Elimination funds cooperative agreements with city health departments to expand LTBI testing in shelters, though coverage remains patchy; as of 2025, only 18 states reported achieving >70% LTBI testing coverage in homeless facilities, per CDC annual reports.
Critically, these programs operate within a fragmented funding landscape. Medicaid expansion under the ACA has improved access in 40 states, but 10 states still refuse expansion, leaving over 1.2 million low-income adults—many at risk of homelessness—in a coverage gap. Even in expansion states, reimbursement for street medicine and mobile clinics remains inconsistent, with many providers relying on philanthropy to cover gaps. The Health Resources and Services Administration (HRSA) funds Health Care for the Homeless (HCH) grants, but these cover only ~30% of estimated need, according to a 2024 Kaiser Family Foundation analysis.
Global Parallels: Lessons from Abroad
The U.S. Is not alone in facing this challenge, though its approach lags behind some high-income peers. In the UK, the NHS’s Pathway model—integring homeless health coordinators into hospital teams—reduced 30-day readmissions by 28% in a 2022 Lancet Public Health evaluation. France’s “Un chez-soi d’abord” (Housing First) initiative, scaled nationally after successful trials in Paris and Lyon, combines immediate housing with assertive community treatment (ACT) teams, resulting in a 40% reduction in emergency department employ among participants over three years, per INSERM data. These models succeed because they decouple healthcare access from behavioral compliance—a stark contrast to U.S. Programs that often tie housing or treatment access to sobriety or treatment adherence, inadvertently penalizing the most vulnerable.
Contraindications & When to Consult a Doctor
This discussion does not pertain to a specific medical treatment, but rather to systemic barriers in care access. However, individuals experiencing homelessness should seek immediate medical attention for:
- Chest pain, shortness of breath, or sudden weakness—possible signs of heart attack or stroke.
- Persistent cough with fever or night sweats lasting >2 weeks—potential tuberculosis.
- Non-healing foot wounds, especially in those with diabetes—high risk for infection and amputation.
- Severe depression, hallucinations, or thoughts of self-harm—requires urgent psychiatric evaluation.
Trust in care begins with being believed. If a provider dismisses your concerns, you have the right to seek a second opinion or request a patient advocate. Many cities offer medical respite programs and street medicine teams that provide judgment-free care—contact local 211 or homeless coalitions for referrals.
The Path Forward: Trust as a Clinical Intervention
Medical mistrust is not a fixed trait of individuals—it is a measurable outcome of how healthcare systems treat the most marginalized. The data demonstrate that when care is delivered with consistency, dignity, and cultural humility—when providers show up not just in clinics but under bridges and in encampments—engagement rises, outcomes improve, and lives are saved. Scaling these models requires more than goodwill: it demands sustained funding, policy reform to decouple care from punitive conditions, and investment in workforce training that centers lived experience. As Dr. Margot Kushel, Professor of Medicine at UCSF and Director of the UCSF Benioff Homelessness and Housing Initiative, stated in a 2024 interview with Health Affairs:
“We are not failing because we lack effective treatments for hypertension, TB, or HIV. We are failing because we refuse to deliver them in ways that respect the autonomy and dignity of people whose lives have been shattered by poverty and racism. Trust is not soft—it is the hardest, most essential clinical skill we have.”
Similarly, Dr. Thomas Byrne, Associate Professor at Boston University School of Social Work and lead evaluator of the BHCHP LTBI program, emphasized in a 2023 CDC-sponsored webinar:
“You can’t outsource trust to a pamphlet. It’s built in the repetition of small acts: showing up when you say you will, remembering someone’s name, treating their pain like it matters. That’s what changes trajectories.”
Until healthcare systems prioritize these human elements as rigorously as they monitor HbA1c or viral load, the mortality gap will persist—not as an inevitability, but as a choice.
